To evaluate the adaptability of the DARDN sequence feature identification method, we applied it on five other cancer types where cancer-specific CTCF sites were identified in our previous work [4], acute myeloid leukemia (AML), breast invasive carcinoma (BRCA), colorectal cancer (CRC), lung adenocarcinoma (LUAD), and prostate adenocarcinoma (PRAD), using the moderate input sequence length of 10 kbps. This evidence concerns the gene CTCF and lung adenocarcinoma.